CKNG8291 just think, if I am China vaccine producer, You would deal with government or individual agent like solution ? for China, they will sure take this opportunity to built up the relationship between country, therefore, it will be country to country deal. solution is just secondary or maybe not in the supply line.The MOU is just make you fool.
FYI there is no way gov will deal directly. The dealing should be through a company which is currently both solution and bintai doing with the respective party. Before invest in any company think first about their buss and processes.
You think they inked MOU without foresee all these challenges. Gov will assist in certain manner. If that's the case you wouldn't have any pharmaceutical company in this country apart that 2 gov linked company.
Investors pls trust on what you invest.. Don't blindly follow rumours then be panic. Tks
01 Oct | 10:48am HLIB Research foresees no more OPR cuts in FY20 01 Oct | 10:25amMid-morning Market KLCI subdued as manufacturing sector loses momentum, banks and...
WORLD POLITICS The U.S. and China could slip into a ‘new cold war’ that pushes countries to pick sides PUBLISHED WED, SEP 30 20209:12 PM EDTUPDATED 2 HOURS AGO
I can’t remember whether I posted here or in the Bintai thread but I had opined before that maybe Solutn and/or Bintai may partner with either Pharma and/or Dpharma for distribution/logistics. It’s partly political but also logical
anthonytkh I can’t remember whether I posted here or in the Bintai thread but I had opined before that maybe Solutn and/or Bintai may partner with either Pharma and/or Dpharma for distribution/logistics. It’s partly political but also logical 01/10/2020 4:57 PM
Wow, I like this ROSY prediction of Solut. Easy money from Syndicates donations to Bilis. Yeee haaa. Syndicates want to donate to bilis at Rm3.00 Apa.... tak payah tunggu lagi... BELI BANYAK LAH... TP 3.00 kata Datuk Seri...
KUALA LUMPUR (Oct 2): Kenanga Research said Dparma is poised to benefit from a vaccine with its well-integrated logistics and distribution network nationwide, and an already existing small volume injectable (SVI) plant in Puchong, which is suitable for the “fill and finish” of inactivated/killed vaccines.
In a daily technical highlight note today, the research house said the stock recently found support for its 50-day simple moving average (SMA), while forming a bullish “pennant” pattern
It’s no longer an MoU, it has progressed to an Agreement as announced by Solutn. We await CanSino Phase3 results. We await GOM decision. Right now, vaccine counters are still speculative-driven largely by retailers that bought when these counters/GOM announced officially back then
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Zuliana
5,395 posts
Posted by Zuliana > 2020-10-01 07:25 |
Post removed.Why?